Chronic Osteomyelitis

被引:34
作者
Uckay, Ilker [1 ,2 ,3 ,4 ,5 ]
Jugun, Kheeldass [1 ,2 ]
Gamulin, Axel [1 ,2 ]
Wagener, Joe [1 ,2 ]
Hoffmeyer, Pierre [1 ,2 ]
Lew, Daniel [3 ,4 ]
机构
[1] Univ Geneva, Univ Hosp Geneva, Orthoped Surg Serv, Geneva, Switzerland
[2] Univ Geneva, Fac Med, Geneva, Switzerland
[3] Univ Geneva, Infect Dis Serv, Univ Hosp Geneva, Geneva, Switzerland
[4] Univ Geneva, Fac Med, Geneva, Switzerland
[5] Univ Hosp Geneva, Infect Dis Serv, Orthopaed Surg Serv, CH-1211 Geneva 14, Switzerland
关键词
Osteomyelitis; Surgery; Antibiotic therapy; Duration; Penetration; Recurrence; METHICILLIN-RESISTANT; CONSERVATIVE MANAGEMENT; ANTIMICROBIAL AGENTS; ANTIBIOTIC-TREATMENT; HYPERBARIC-OXYGEN; THERAPY; BONE; VANCOMYCIN; INFECTIONS; FOOT;
D O I
10.1007/s11908-012-0286-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Chronic osteomyelitis is a multifaceted bacterial infection with common features. It absolutely requires surgery for remission. The duration and form of concomitant administration of antibiotic agents for adult patients is still based on expert opinion. The traditional recommendation of 6-12 weeks of antibiotic therapy, where, for at least the first 2-6 weeks, antibiotics should be administered intravenously, is more and more challenged in favor of an oral antibiotic treatment with selected agents from the start. There is no evidence that the total duration of antibiotic therapy for more than 4-6 weeks improves outcome, when compared with shorter regimens. Hopefully, the future will show randomized trials in the adult population, allowing optimal timing of surgical and medical therapy and sparing of unnecessary prescription, with concomitant development of antibiotic resistance. External advice from an expert team with combined surgeons and infectious disease physicians may help to reduce antibiotic consumption in a cost-effective way.
引用
收藏
页码:566 / 575
页数:10
相关论文
共 98 条
[41]  
Hannan Catherine M, 2009, Semin Plast Surg, V23, P132, DOI 10.1055/s-0029-1214165
[42]   Septic Arthritis in Adults with Sickle Cell Disease Often is Associated with Osteomyelitis or Osteonecrosis [J].
Hernigou, Philippe ;
Daltro, Gildasio ;
Flouzat-Lachaniette, Charles-Henri ;
Roussignol, Xavier ;
Poignard, Alexandre .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2010, 468 (06) :1676-1681
[43]   Antimicrobial Agents in Treatment of MRSA Infections [J].
Johnson, Mark D. ;
Decker, Catherine F. .
DM DISEASE-A-MONTH, 2008, 54 (12) :793-800
[44]   Carrier systems for the local delivery of antibiotics in bone infections [J].
Kanellakopoulou, K ;
Giamarellos-Bourboulis, EJ .
DRUGS, 2000, 59 (06) :1223-1232
[45]   Fluoroquinolones versus β-lactam based regimens for the treatment of osteomyelitis a meta-analysis of randomized controlled trials [J].
Karamanis, Eirinaios M. ;
Matthaiou, Dimitrios K. ;
Moraitis, Lampros I. ;
Falagas, Matthew E. .
SPINE, 2008, 33 (10) :E297-E304
[46]   Cierny-Mader Type III chronic osteomyelitis: the results of patients treated with debridement, irrigation, vancomycin beads and systemic antibiotics [J].
Kinik, Hakan ;
Karaduman, Mert .
INTERNATIONAL ORTHOPAEDICS, 2008, 32 (04) :551-558
[47]  
Lack William, 2010, Iowa Orthop J, V30, P174
[48]   Q fever osteoarticular infection: four new cases and a review of the literature [J].
Landais, C. ;
Fenollar, F. ;
Constantin, A. ;
Cazorla, C. ;
Guilyardi, C. ;
Lepidi, H. ;
Stein, A. ;
Rolain, J. M. ;
Raoult, D. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (05) :341-347
[49]   Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? [J].
Lazzarini, L ;
Lipsky, BA ;
Mader, JT .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (03) :127-138
[50]  
LEFROCK JL, 1992, EUR J SURG, P9